Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 5
2004 6
2005 3
2006 5
2007 3
2008 11
2009 17
2010 19
2011 14
2012 11
2013 17
2014 15
2015 11
2016 15
2017 16
2018 14
2019 10
2020 17
2021 15
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

208 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean yong min kim (196 results)?
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.
Colombo N, Dubot C, Lorusso D, Caceres MV, Hasegawa K, Shapira-Frommer R, Tewari KS, Salman P, Hoyos Usta E, Yañez E, Gümüş M, Olivera Hurtado de Mendoza M, Samouëlian V, Castonguay V, Arkhipov A, Toker S, Li K, Keefe SM, Monk BJ; KEYNOTE-826 Investigators. Colombo N, et al. N Engl J Med. 2021 Nov 11;385(20):1856-1867. doi: 10.1056/NEJMoa2112435. Epub 2021 Sep 18. N Engl J Med. 2021. PMID: 34534429 Clinical Trial.
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.
Makker V, Colombo N, Casado Herráez A, Santin AD, Colomba E, Miller DS, Fujiwara K, Pignata S, Baron-Hay S, Ray-Coquard I, Shapira-Frommer R, Ushijima K, Sakata J, Yonemori K, Kim YM, Guerra EM, Sanli UA, McCormack MM, Smith AD, Keefe S, Bird S, Dutta L, Orlowski RJ, Lorusso D; Study 309–KEYNOTE-775 Investigators. Makker V, et al. Among authors: kim ym. N Engl J Med. 2022 Feb 3;386(5):437-448. doi: 10.1056/NEJMoa2108330. Epub 2022 Jan 19. N Engl J Med. 2022. PMID: 35045221 Clinical Trial.
Survival with Cemiplimab in Recurrent Cervical Cancer.
Tewari KS, Monk BJ, Vergote I, Miller A, de Melo AC, Kim HS, Kim YM, Lisyanskaya A, Samouëlian V, Lorusso D, Damian F, Chang CL, Gotovkin EA, Takahashi S, Ramone D, Pikiel J, Maćkowiak-Matejczyk B, Guerra Alía EM, Colombo N, Makarova Y, Rischin D, Lheureux S, Hasegawa K, Fujiwara K, Li J, Jamil S, Jankovic V, Chen CI, Seebach F, Weinreich DM, Yancopoulos GD, Lowy I, Mathias M, Fury MG, Oaknin A; Investigators for GOG Protocol 3016 and ENGOT Protocol En-Cx9. Tewari KS, et al. Among authors: kim ym. N Engl J Med. 2022 Feb 10;386(6):544-555. doi: 10.1056/NEJMoa2112187. N Engl J Med. 2022. PMID: 35139273 Clinical Trial.
Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial.
Youn JW, Hur SY, Woo JW, Kim YM, Lim MC, Park SY, Seo SS, No JH, Kim BG, Lee JK, Shin SJ, Kim K, Chaney MF, Choi YJ, Suh YS, Park JS, Sung YC. Youn JW, et al. Among authors: kim ym. Lancet Oncol. 2020 Dec;21(12):1653-1660. doi: 10.1016/S1470-2045(20)30486-1. Lancet Oncol. 2020. PMID: 33271094 Clinical Trial.
Current medical treatment of uterine fibroids.
Sohn GS, Cho S, Kim YM, Cho CH, Kim MR, Lee SR; Working Group of Society of Uterine Leiomyoma. Sohn GS, et al. Among authors: kim ym. Obstet Gynecol Sci. 2018 Mar;61(2):192-201. doi: 10.5468/ogs.2018.61.2.192. Epub 2018 Feb 13. Obstet Gynecol Sci. 2018. PMID: 29564309 Free PMC article. Review.
Erratum: Author correction.
Lee YJ, Kim YM, Kim HJ, Choi SW, Lee SW, Park JY, Kim DY, Suh DS, Kim JH, Kim YT, Nam JH. Lee YJ, et al. Among authors: kim ym. Obstet Gynecol Sci. 2017 Nov;60(6):621. doi: 10.5468/ogs.2017.60.6.621. Epub 2017 Oct 31. Obstet Gynecol Sci. 2017. PMID: 29185544 Free PMC article.
Role of minimally invasive surgery in early ovarian cancer.
Lim CK, Kim DY, Cho A, Choi JY, Park JY, Kim YM. Lim CK, et al. Among authors: kim ym. Gland Surg. 2021 Mar;10(3):1252-1259. doi: 10.21037/gs-2019-ursoc-07. Gland Surg. 2021. PMID: 33842272 Free PMC article. Review.
Erratum: Correction of Acknowledgements.
Park YR, Kim YM, Lee SW, Lee HY, Lee GE, Lee JE, Kim YT. Park YR, et al. Among authors: kim ym. Obstet Gynecol Sci. 2018 Jul;61(4):537. doi: 10.5468/ogs.2018.61.4.537. Epub 2018 Jul 10. Obstet Gynecol Sci. 2018. PMID: 30018911 Free PMC article.
208 results